Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lanzhou Ion Therapy is a Chinese medical device company focused on the design, manufacture, installation, commissioning, operation, and maintenance of carbon ion and heavy ion radiotherapy systems for cancer treatment. Founded in 2002 in Lanzhou, the company is affiliated with the Institute of Modern Physics of the Chinese Academy of Sciences through CAS Ion Medical Technology. It is one of the few domestic Chinese companies with end-to-end capabilities in heavy ion medical machine development and has supplied carbon ion therapy systems for multiple hospital projects in China. Its Lanzhou carbon ion therapy system has received Chinese regulatory approval, and the company continues to expand installations at oncology centers across the country. The business is best characterized as an advanced radiation oncology equipment developer rather than a drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lanzhou Ion Therapy.